Pigmentary disorders


Depigmentation therapy refers to medical treatments that remove skin pigmentation. Depigmentation therapy is used in someone that has widespread, but incomplete, vitiligo on the face and/or other sites, in an attempt to improve their appearance. The most commonly used depigmenting agent is monobenzyl ether of hydroquinone (MBEH). If the patient cannot tolerate MBEH, or if treatment fails, combination therapies or other treatments may be considered. Depigmentation therapy may be considered in the management of treatment resistant vitiligo affecting more than 50% of the body surface area or affecting cosmetically sensitive, exposed body sites


    Related Conference of Pigmentary disorders

    December 09-09, 2021

    3rd Geriatrics and Healthcare Conference: For a better Aging Care

    Singapore City, Singapore
    December 09-09, 2021

    4th International Dermatology Conference: Skin and Body

    Amsterdam, Netherlands
    January 28-29, 2022

    2nd Global Summit on Skincare and Plastic Aesthetic

    Singapore City,Singapore
    April 13-14, 2022

    27th world Congress & expo on Dermatology

    Perth, Australia
    May 15-16, 2022

    7th World Dermatology, Trichology and Aesthetic Congress

    Amsterdam, Netherlands
    May 18-19, 2022

    24th World Dermatology and Aesthetic Congress

    Tokyo, Japan
    June 20-21, 2022

    23rd World Dermatology Congress

    Paris, France
    July 18-19, 2022

    globaldermatology-2022

    Amsterdam, Netherlands
    July 20-21, 2022

    22nd European Dermatology Congress

    Paris, France

    Pigmentary disorders Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in